Dr. Thomas Davenport and Dr. Peter Moyer will present their clinical experience utilizing AmchoPlastTM, a sterile dehydrated human amnion intermediate layer chorion membrane allograft (dHAICM), in soft tissue reconstruction and the management of chronic wounds. This session will begin with an overview of Cellution Biologics and the scientific rationale for amniotic tissue use, followed by a detailed discussion of the tri-layer structure, including its key growth factors and associated clinical benefits. The presenters will also review interim results from a randomized controlled trial, highlighting emerging evidence supporting AmchoPlast®, and conclude with real-world case presentations demonstrating practical application and outcomes in complex wound care settings. 

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.